Essilor, recently launched Stellest™ lens, a new generation of spectacle lens solutions in the fight against myopia. Interim findings after one year of an ongoing clinical trial show more than 60% slowdown in myopia progression on average when compared to children wearing single vision lenses.

Myopia today represents a global health crisis, with five billion people, or half of the world’s population, expected to be myopic by 2050. It can progress rapidly in children and may lead to sight-threatening eye diseases such as glaucoma, cataracts, retinal detachment, and macular degeneration later in life. When detected early, myopia control solutions can help in slowing down its progression in children, reducing such risks and ensuring a better quality of life.